neutral
Recently
Medline targets $5 billion raise in major US IPO
Medline plans a $5 billion IPO backed by over $23 billion in revenue, marking one of 2025’s largest US listings.
Medline Inc is preparing one of the largest US IPOs of the year, targeting proceeds of about $5 billion through the sale of 179 million shares, with listing expected on December 17. The medical supplies company reported FY25 revenue of approximately $23.5 billion and EBITDA near $3.2 billion, supporting an implied valuation close to $50 billion.